新诺威:2025年度非经营性资金占用及其他关联资金往来情况汇总表

石药创新制药股份有限公司

                          石药创新制药股份有限公司 2025 年度非经营性资金占用及其他关联资金往来情况汇总表

                                                                                                                        人民币万元

                          资金占用方    占用方与上市公  上市公司  2025年年初占  2025年度占用  2025年度占用  2025年度偿  2025年年  占用

    非经营性资金占用        名称        司的关联关系    核算的会    用资金余额    累计发生金额    资金的利息  还累计发生  末占用资  形成  占用性质
                                                            计科目                    (不含利息)        (如有)        金额      金余额    原因

 控股股东、实际控制人        无              无            无          无            无            无          无        无      无    不适用
    及其附属企业
 小计

 前控股股东、实际控制人      无              无            无          无            无            无          无        无      无    不适用
    及其附属企业
 小计

 其他关联方及其附属企业      无              无            无          无            无            无          无        无      无    不适用

 小计
 总计

石药创新制药股份有限公司

                        石药创新制药股份有限公司 2025 年度非经营性资金占用及其他关联资金往来情况汇总表 - 续

                                                                                                                        人民币万元

      其他关联资金往来                  资金往来方名称              往来方与上市公司的关联关系    上市公司核算    2025年年初往来    2025年度往来累计    2025年度往来资    2025年度偿还累计    2025年年末往来资    往来形    往来性质

                                                                                                      的会计科目        资金余额      发生金额(不含利息)  金的利息(如有)        发生金额              金余额        成原因

                                    石药集团欧意药业有限公司        股东、受同一控股股东及最终控      应收账款              764.09            5,067.34                -            2,034.61            3,796.82    货款    经营性往来

                                                                          制方控制的其他企业

                                    石药集团欧意药业有限公司        股东、受同一控股股东及最终控    应收款项融资          3,167.43              416.59                -            3,558.70                25.32    货款    经营性往来

                                                                          制方控制的其他企业

                                    石药集团欧意药业有限公司        股东、受同一控股股东及最终控      应收票据            1,590.04            1,605.91                -            2,592.30              603.65    货款    经营性往来

                                                                          制方控制的其他企业

                                  石药集团恩必普药业有限公司        股东、受同一控股股东及最终控      应收账款                    -                3.30                -                3.30                    -    货款    经营性往来

                                                                          制方控制的其他企业

                                  石药集团恩必普药业有限公司        股东、受同一控股股东及最终控    应收款项融资                  -                3.30                -                    -                3.30    货款    经营性往来

                                                                          制方控制的其他企业

                                    内蒙古常盛制药有限公司          受同一控股股东及最终控制方控      应收账款                    -            2,922.00                -            2,721.00              201.00    货款    经营性往来

                                                                            制的其他企业

                                    内蒙古常盛制药有限公司          受同一控股股东及最终控制方控    应收款项融资            355.36            2,389.18                -            2,263.54              481.00    货款    经营性往来

                                                                            制的其他企业

                                    内蒙古常盛制药有限公司          受同一控股股东及最终控制方控      应收票据              500.39              331.82                -              619.93              212.28    货款    经营性往来

                                                                            制的其他企业

                                      石药银湖制药有限公司          受同一控股股东及最终控制方控      应收账款              265.24              554.72                -              484.21              335.75    货款    经营性往来

                                                                            制的其他企业

                                      石药银湖制药有限公司          受同一控股股东及最终控制方控    应收款项融资            58.64              257.17                -              293.77                22.04    货款    经营性往来

  控股股东、实际控制人                                                      制的其他企业

      及其附属企业                                                  受同一控股股东及最终控制方控                            80.46              225.97                -              268.30                38.13

                                      石药银湖制药有限公司                  制的其他企业              应收票据                                                                                                          货款    经营性往来

                                  石药集团河北中诚医药有限公司      受同一控股股东及最终控制方控      应收账款              40.70            3,780.63                -            3,680.88              140.45    货款    经营性往来

                                                                            制的其他企业

                                  石药集团河北中诚医药有限公司